Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 07, 2024

BUY
$6.29 - $9.15 $83,028 - $120,780
13,200 New
13,200 $88,000
Q3 2023

Nov 14, 2023

SELL
$5.52 - $9.5 $83,352 - $143,450
-15,100 Reduced 36.74%
26,000 $143,000
Q2 2023

Aug 11, 2023

BUY
$6.69 - $11.99 $274,959 - $492,789
41,100 New
41,100 $350,000
Q4 2022

Feb 14, 2023

BUY
$9.71 - $15.86 $547,644 - $894,504
56,400 New
56,400 $575,000

Others Institutions Holding CTKB

About Cytek Biosciences, Inc.


  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $726M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.